Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: Comparison with apoprotein CIII
- 1 June 2003
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 63 (6) , 2171-2177
- https://doi.org/10.1046/j.1523-1755.2003.00019.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Atherosclerotic cardiovascular disease risks in chronic hemodialysis patientsKidney International, 2000
- Accumulation of Apolipoprotein C-I–Rich and Cholesterol-Rich VLDL Remnants During Exaggerated Postprandial Triglyceridemia in Normolipidemic Patients With Coronary Artery DiseaseCirculation, 2000
- Lipoprotein abnormalities in diabetic nephropathyKidney International, 1999
- The compositional abnormalities of lipoproteins in diabetic renal failureNephrology Dialysis Transplantation, 1998
- In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.Journal of Clinical Investigation, 1996
- Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.Journal of Clinical Investigation, 1996
- Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failureNephrology Dialysis Transplantation, 1996
- Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factorsDiabetologia, 1987
- The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease.Circulation, 1987
- Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemiasAtherosclerosis, 1983